| [1] |
Shao X, Hockley BG, Hoareau R, et al. Fully automated preparation of[11C] choline and[18F] fluoromethylcholine using TracerLab synthesis modules and facilitated quality control using analytical HPLC[J]. Appl Radiat Isot, 2011, 69(2): 403-409. doi: 10.1016/j.apradiso.2010.09.022
|
| [2] |
Slaets D, De Bruyne S, Dumolyn C, et al. Reduced dimethylaminoethanol in [18F] fluoromethylcholine: an important step towards enhanced tumour visualization[J]. Eur J Nucl Med Mol Imaging, 2010, 37(11): 2136-2145. doi: 10.1007/s00259-010-1508-z
|
| [3] |
Piel M, Bauman A, Baum R, et al. Improved automated synthesis of[18F] fluoroethylcholine for prostate cancer imaging using PET/CT[J]. J Nucl Med, 2006, 47(Supple 1): 135-137.
|
| [4] |
Pascali G, D′Antonio L, Bovone P, et al. Optimization of automated large-scale production of [18F] fluoroethylcholine for PET prostate cancer imaging[J]. Nucl Med Biol, 2009, 36(5): 569-574. doi: 10.1016/j.nucmedbio.2009.01.004
|
| [5] |
Piel M, Bauman A, Baum RP, et al. Improved automated synthesis of [18F]fluoroethylcholine as a radiotracer for cancer imaging[J]. Bioorg Med Chem, 2007, 15(9): 3171-3175. doi: 10.1016/j.bmc.2007.02.038
|
| [6] |
Li Z, Vance DE. Phosphatidylcholine and choline homeostasis[J]. J Lipid Res, 2008, 49(6): 1187-1194. doi: 10.1194/jlr.R700019-JLR200
|
| [7] |
周丽娜, 吴宁. PET/CT新型分子显像剂在肿瘤个体化药物治疗中的应用[J].国际医学放射学杂志, 2011, 34(1): 61-64. doi: 10.3784/j.issn.1674-1897.2011.01.Z0112
|
| [8] |
Zhang H, Tian M, Oriuchi N, et al. 11C-choline PET for the detection of bone and soft tissue tumours in comparison with FDG PET[J]. Nucl Med Commun, 2003, 24(3): 273-279.
|
| [9] |
Kwee SA, DeGrado TR, Talbot JN, et al. Cancer imaging with fluorine-18-labeled choline derivatives[J]. Semin Nucl Med, 2007, 37(6): 420-428. doi: 10.1053/j.semnuclmed.2007.07.003
|